Do affluent societies have the only options for the best therapy?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Establishing Hematopoietic Stem Cell Transplant Unit in Resource Limited Setting: A Critical Analysis of Indian Council of Medical Research 2017 Guidelines.Journal of transplantation · 2018
   Review
2. Quantitative and qualitative differences in use and trends of hematopoietic stem cell transplantation: a Global Observational Study.Haematologica · 2013
   Observational
3. Hematopoietic stem cell transplantation: a global perspective.JAMA · 2010
   Article
4. Changes in the use of hematopoietic stem cell transplantation: a model for diffusion of medical technology.Haematologica · 2010
   Article
5. A simplified method for stem cell autografting in multiple myeloma: a single institution experience.Bone marrow transplantation · 2009
   Article
6. A single apheresis procedure in the donor may be enough to complete an allograft using the "Mexican method" of non-ablative allografting.Blood transfusion = Trasfusione del sangue · 2009
   Article
7. Special issues related to hematopoietic SCT in the Eastern Mediterranean region and the first regional activity report.Bone marrow transplantation · 2009
   Article
8. Therapeutic choices in patients with Ph-positive CML living in Mexico in the tyrosine kinase inhibitor era: SCT or TKIs?Bone marrow transplantation · 2008
   Article
9. Globalization of treatment strategies in leukemia: challenges and responsibilities.Leukemia · 2008
   Article
10. Has stem cell transplantation come of age in the treatment of sickle cell disease?Bone marrow transplantation · 2007
    Review
11. Haematological malignancies in developing countries: is CML the commonest childhood leukaemia?Leukemia · 2007
    Article

Corrections and comments

• Commented on by
  Haematological malignancies in developing countries: is CML the commonest childhood leukaemia?2007
• Comment on
  Hematopoietic stem cell transplants for chronic myeloid leukemia in Europe--impact of cost considerations.2007

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as